EP Patent

EP2079456B1 — Pharmaceutical cyclosporin compositions

Assigned to Sigmoid Pharma Ltd · Expires 2012-12-05 · 13y expired

What this patent protects

An oral composition comprising minicapsules wherein the minicapsules comprise one or more therapeutic or prophylactic substances in a liquid, semi-liquid, or solid core. The minicapsules have release profiles to release the substance in an active form at one or more sites along t…

USPTO Abstract

An oral composition comprising minicapsules wherein the minicapsules comprise one or more therapeutic or prophylactic substances in a liquid, semi-liquid, or solid core. The minicapsules have release profiles to release the substance in an active form at one or more sites along the gastro-intestinal tract to maximise absorption and/or therapeutic efficiency.

Drugs covered by this patent

Patent Metadata

Patent number
EP2079456B1
Jurisdiction
EP
Classification
—
Expires
2012-12-05
Drug substance claim
No
Drug product claim
No
Assignee
Sigmoid Pharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.